0.000
0.00 (0.00%)
| Avg. Volume (3M) | 37 |
| Market Cap | 351 |
| 52 Weeks Range | |
| Earnings Date | 4 Jun 2025 - 6 Jun 2025 |
| Profit Margin | -102.77% |
| Operating Margin (TTM) | -105.91% |
| Diluted EPS (TTM) | -12.63 |
| Quarterly Revenue Growth (YOY) | 5.40% |
| Total Debt/Equity (MRQ) | 8.62% |
| Current Ratio (MRQ) | 2.40 |
| Operating Cash Flow (TTM) | -11.51 M |
| Levered Free Cash Flow (TTM) | -2.25 M |
| Return on Assets (TTM) | -23.39% |
| Return on Equity (TTM) | -61.27% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Bearish | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Bearish | Mixed | |
| Stock | Clever Leaves Holdings Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -1.00 |
|
Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments namelyThe Cannabinoid operating segment which is comprised of the company’s cultivation, extraction, and commercialization of cannabinoid products; and Non-Cannabinoid operating segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 21.79% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |